Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04896151 · ClinicalTrials.gov registry record · NA

Assessing the Utility of MMPI-2-RF-EX in Detecting Simulated Underreporting of Current Suicide Risk in Military Veterans

A NA study of Suicidal Ideation and Suicidal, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT04896151: Completed NA study of Suicidal Ideation and Suicidal, sponsored by Ohio State University.

NCT04896151 is a NA study of Suicidal Ideation and Suicidal that has completed, run by Ohio State University. The registered enrollment target is 75 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04896151, a NA study of Suicidal Ideation and Suicidal, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The aim of the current project are is examine the incremental predictive utility of the MMPI-2-RF-EX validity scales in detecting simulated underreporting of suicide risk on the MMPI-2-RF-EX and other self-report measures of suicide risk in 150 military Veterans experiencing past-month death or suicidal ideation.

Primary Outcome

The MMPI-2-RF-EX Suicidal/Death Ideation scale is a self-report measure of current suicide risk contained within the instrument. T scores range from 45 to 100, with higher scores indicative of greater suicide risk.

Interventions

  • DIAGNOSTIC_TEST Minnesota Multiphasic Personality Inventory -2- Restructured Form - Experimental

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2021-05-15
Est. Completion 2023-02-14
Phase NA
Ohio State University

552 total trials

What the finished NCT04896151 record still lists

NCT04896151 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (72% lower).

The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Minnesota Multiphasic Personality Inventory -2- Restructured Form - Experimental is the first listed.

NCT04896151 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04896151 about?

NCT04896151 is a clinical study titled "Assessing the Utility of MMPI-2-RF-EX in Detecting Simulated Underreporting of Current Suicide Risk in Military Veterans". The aim of the current project are is examine the incremental predictive utility of the MMPI-2-RF-EX validity scales in detecting simulated underreporting of suicide risk on the MMPI-2-RF-EX and other self-report measures of suicide risk in 150 military Veterans experiencing past-month death or suic...

What is the current status of trial NCT04896151?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2021-05-15. Estimated completion is 2023-02-14.

What conditions does trial NCT04896151 study?

This clinical trial studies the following conditions: Suicidal Ideation, Suicidal.

What interventions are being tested in trial NCT04896151?

The interventions under investigation include: Minnesota Multiphasic Personality Inventory -2- Restructured Form - Experimental (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04896151?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04896151 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04896151's enrollment target sits among peer trials

75 54th of 84 higher than 30 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04896151, the US trial registry maintained by the National Library of Medicine. NCT04896151 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.